Vikas Ecotech Fair Value
Vikas Ecotech (VIKASECO) average fair value is ₹14.77 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹1.4 (+955.29%), fair value range ₹0.24–₹41.7. For live price and a broader fundamental view, visit VIKASECO stock overview.
Fair Value Analysis Export
VIKASECO Fair Value vs Current Price — Valuation Summary
VIKASECO average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. Explore VIKASECO intrinsic value to estimate fundamental worth using multiple valuation models.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
VIKASECO Fair Value Analysis — Data Sources & Coverage
Vikas Ecotech financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Examine Vikas Ecotech quarterly financials for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
VIKASECO vs Chemicals Sector Peers — P/E, P/B & Market Cap
Vikas Ecotech P/E ratio, P/B ratio and market capitalisation vs Chemicals sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Polychem | POLYCHEM | - | 1.8 | ₹86 |
| Kanchi Karpooram | KANCHI | 29.19 | 0.7 | ₹148 |
| Blue Pearl Agriventures | BPAGRI | 2564.0 | 25.33 | ₹1,622 |
| Omkar Pharmachem | OMKARPH | 157.39 | 3.03 | ₹29 |
| Beezaasan Explotech | BEEZAASAN | 20.83 | 1.94 | ₹309 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.